Skip to main content

Table 2 Baseline characteristics and comorbidities based on sex in patients with idiopathic pulmonary fibrosis

From: Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study

 

Total

Men

Women

p value

 

(n = 21,111)

(n = 15,029)

(n = 6082)

 

Respiratory diseases

COPD

7882 (37.34%)

6099 (40.58%)

1783 (29.32%)

 < 0.001

Lung cancer

706 (3.34%)

618 (4.11%)

88 (1.45%)

 < 0.001

Pulmonary embolism

338 (1.60%)

232 (1.54%)

106 (1.74%)

0.296

Pulmonary hypertension

315 (1.49%)

167 (1.11%)

148 (2.43%)

 < 0.001

Obstructive sleep apnoea

65 (0.31%)

55 (0.37%)

10 (0.16%)

0.017

Non-respiratory diseases

GERD

14,953 (70.83%)

10,495 (69.83%)

4458 (73.30%)

 < 0.001

Dyslipidaemia

13,286 (62.93%)

9411 (62.62%)

3875 (63.71%)

0.136

Hypertension

12,464 (59.04%)

8817 (58.67%)

3647 (59.96%)

0.083

Diabetes mellitus

9483 (44.92%)

6977 (46.42%)

2506 (41.20%)

 < 0.001

Ischaemic heart disease

5431 (25.73%)

4118 (27.40%)

1313 (21.59%)

 < 0.001

Anxiety

4238 (20.07%)

2730 (18.16%)

1508 (24.79%)

 < 0.001

Depression

3142 (14.88%)

2007 (13.35%)

1135 (18.66%)

 < 0.001

Congestive heart failure

2887 (13.68%)

1992 (13.25%)

895 (14.72%)

0.005

CCI

0.001

0

577 (2.73%)

423 (2.81%)

154 (2.53%)

 

1

3109 (14.73%)

2196 (14.61%)

913 (15.01%)

 

2

4109 (19.46%)

2887 (19.21%)

1222 (20.09%)

 

3

3823 (18.11%)

2642 (17.58%)

1181 (19.42%)

 

 ≥ 4

9493 (44.97%)

6881 (45.78%)

2612 (42.95%)

 

CCI, mean (standard deviation)

3.67 (2.40)

3.74 (2.48)

3.51 (2.20)

 < 0.001

  1. All values are presented as number (%)
  2. CCI Charlson comorbidity index, COPD chronic obstructive pulmonary disease, GERD gastro-oesophageal reflux disease
  3. P values calculated by chi-square tests or Wilcoxon rank sums test